| Joseph Botta Md & Associates Llc | |
|
150 Ware Rd Dayville CT 06241-1126 | |
| (860) 779-5093 | |
| (860) 779-5095 |
| Full Name | Joseph Botta Md & Associates Llc |
|---|---|
| Speciality | Internal Medicine |
| Location | 150 Ware Rd, Dayville, Connecticut |
| Authorized Official Name and Position | Joseph J Botta (PHYSICIAN/OWNER) |
| Authorized Official Contact | 8607795093 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Joseph Botta Md & Associates Llc 150 Ware Rd Dayville CT 06241-1126 Ph: (860) 779-5093 | Joseph Botta Md & Associates Llc 150 Ware Rd Dayville CT 06241-1126 Ph: (860) 779-5093 |
| NPI Number | 1659511046 |
|---|---|
| Provider Enumeration Date | 02/25/2009 |
| Last Update Date | 02/25/2009 |
| Medicare PECOS PAC ID | 2365508306 |
|---|---|
| Medicare Enrollment ID | O20090227000142 |
News Archive
When Sen. Joe Negron released a proposal Monday to cut at least $1 billion from health- and human-services programs, it was a first step in what likely will be a contentious budget process. The proposal immediately drew criticism for deep cuts to hospital funding, mental-health services and the Medically Needy program. And Tuesday, Negron's House counterpart will release a budget proposal that will differ on key issues.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.
An international study led by University of Montreal scientists suggests family history may not be a good predictor of the presence of mutations predisposing to autism or schizophrenia. The findings show how new or de novo gene mutations alterations of the cell's DNA play a role in these devastating conditions.
› Verified 8 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1659511046 | NPI | - | NPPES |
| 010040605CT01 | Other | CT | ANTHEM BCBS |
| 2V2749 | Other | CT | HEALTHNET |
| 1406059 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 040605 (Connecticut) | Primary |
| 207RG0300X | Internal Medicine - Geriatric Medicine | 040605 (Connecticut) | Secondary |
| Provider Name | David L Candow |
|---|---|
| Provider Type | Practitioner - Family Practice |
| Provider Identifiers | NPI Number: 1457365363 PECOS PAC ID: 8224920848 Enrollment ID: I20040329000274 |
News Archive
When Sen. Joe Negron released a proposal Monday to cut at least $1 billion from health- and human-services programs, it was a first step in what likely will be a contentious budget process. The proposal immediately drew criticism for deep cuts to hospital funding, mental-health services and the Medically Needy program. And Tuesday, Negron's House counterpart will release a budget proposal that will differ on key issues.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.
An international study led by University of Montreal scientists suggests family history may not be a good predictor of the presence of mutations predisposing to autism or schizophrenia. The findings show how new or de novo gene mutations alterations of the cell's DNA play a role in these devastating conditions.
› Verified 8 days ago
| Provider Name | Joseph J Botta |
|---|---|
| Provider Type | Practitioner - Geriatric Medicine |
| Provider Identifiers | NPI Number: 1831105360 PECOS PAC ID: 6709890908 Enrollment ID: I20060126000611 |
News Archive
When Sen. Joe Negron released a proposal Monday to cut at least $1 billion from health- and human-services programs, it was a first step in what likely will be a contentious budget process. The proposal immediately drew criticism for deep cuts to hospital funding, mental-health services and the Medically Needy program. And Tuesday, Negron's House counterpart will release a budget proposal that will differ on key issues.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.
An international study led by University of Montreal scientists suggests family history may not be a good predictor of the presence of mutations predisposing to autism or schizophrenia. The findings show how new or de novo gene mutations alterations of the cell's DNA play a role in these devastating conditions.
› Verified 8 days ago
| Provider Name | Ronald W Klare |
|---|---|
| Provider Type | Practitioner - Internal Medicine |
| Provider Identifiers | NPI Number: 1760498539 PECOS PAC ID: 0941350961 Enrollment ID: I20090615000096 |
News Archive
When Sen. Joe Negron released a proposal Monday to cut at least $1 billion from health- and human-services programs, it was a first step in what likely will be a contentious budget process. The proposal immediately drew criticism for deep cuts to hospital funding, mental-health services and the Medically Needy program. And Tuesday, Negron's House counterpart will release a budget proposal that will differ on key issues.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.
An international study led by University of Montreal scientists suggests family history may not be a good predictor of the presence of mutations predisposing to autism or schizophrenia. The findings show how new or de novo gene mutations alterations of the cell's DNA play a role in these devastating conditions.
› Verified 8 days ago
News Archive
When Sen. Joe Negron released a proposal Monday to cut at least $1 billion from health- and human-services programs, it was a first step in what likely will be a contentious budget process. The proposal immediately drew criticism for deep cuts to hospital funding, mental-health services and the Medically Needy program. And Tuesday, Negron's House counterpart will release a budget proposal that will differ on key issues.
University at Buffalo researchers have received part of a $1.5 million grant to investigate light therapy as a replacement for prescription opioids in treating oral mucositis, painful ulcers and swelling in the mouth that result from chemotherapy and radiation treatment for cancer.
Protox Therapeutics Inc., a developer of innovative products for the treatment of urological diseases, today announced financial results and achievements for the quarter ended June 30, 2011.
An international study led by University of Montreal scientists suggests family history may not be a good predictor of the presence of mutations predisposing to autism or schizophrenia. The findings show how new or de novo gene mutations alterations of the cell's DNA play a role in these devastating conditions.
› Verified 8 days ago
Medical Center Of Northeast Connecticut Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 612 Hartford Pike, Dayville, CT 06241 Phone: 860-779-0284 Fax: 860-779-0386 | |
Killingly Medical Center Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 545 Hartford Pike, Dayville, CT 06241 Phone: 860-204-0883 | |
Hope Medical Care Llc Primary Care Clinic Medicare: Medicare Enrolled Practice Location: 17 Ferland Dr, Dayville, CT 06241 Phone: 401-338-0673 |